BioAdaptives, Inc. (BDPT) 은(는) 상장 기업입니다 필수소비재 섹터의 Packaged Foods 산업에서 운영. 본사 소재지는 Las Vegas, NV, 미국. 현재 CEO는 James E. Keener.
BDPT 을(를) 보유 IPO 날짜 2014-07-09, 1 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $109.44K.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
